GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia

Clinical trial NCT04569877 · COMPLETED

Trial details

NCT number: NCT04569877
Sponsor: University of Giessen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome (SARS) Pneumonia COVID-19 Pneumonia

Start date: 2020-09-24
Primary completion: 2022-06-21
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.